Cognitive impairment in people with epilepsy: Montreal Cognitive Assessment (MoCA) as a screening tool.
Cognitive impairment
Epilepsy
Montreal Cognitive Assessment
Neuropsychology
Journal
Acta neurologica Belgica
ISSN: 2240-2993
Titre abrégé: Acta Neurol Belg
Pays: Italy
ID NLM: 0247035
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
01
05
2022
accepted:
19
07
2022
medline:
28
4
2023
pubmed:
5
8
2022
entrez:
4
8
2022
Statut:
ppublish
Résumé
Although cognitive impairment is common in people with epilepsy, it is often neglected in outpatient clinics. MoCA is a simple and reliable test, which was validated for the cognitive screening of Alzheimer's and vascular dementia. The aim of our study was to evaluate MoCA as a tool for a cognitive screening of people with epilepsy. Our study included 50 people with epilepsy and 46 healthy individuals. All participants took the Slovenian version of the MoCA. Mean age, education and MoCA scores were compared between the two groups. There was no significant difference between people with epilepsy and the controls in age (47.6, SD 18.1 vs 50.9, SD 14.0 years) or education (12.8, SD 2.8 vs 13.4, SD 2.8 years). People with epilepsy had significantly lower total MoCA scores than did the controls (23.3, SD 4.5 vs 27.5, SD 1.9 points; p < 0.001). People with epilepsy achieved a lower score in several cognitive domains compared to the control group. MoCA can be used as an appropriate screening tool for cognitive impairment in people with epilepsy in the outpatient clinic. For a more accurate evaluation, neuropsychological assessments should be used.
Identifiants
pubmed: 35925540
doi: 10.1007/s13760-022-02046-4
pii: 10.1007/s13760-022-02046-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
451-456Subventions
Organisme : University Medical Centre Maribor, Maribor, Slovenia
ID : IRP-2018/01-21
Informations de copyright
© 2022. The Author(s) under exclusive licence to Belgian Neurological Society.
Références
Fisher RS, van Emde W, Boas BW et al (2005) Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia 46:470–472. https://doi.org/10.1111/j.0013-9580.2005.66104.x
doi: 10.1111/j.0013-9580.2005.66104.x
pubmed: 15816939
Helmstaedter C, Witt J-A (2017) Epilepsy and cognition – a bidirectional relationship? Seizure 49:83–89. https://doi.org/10.1016/j.seizure.2017.02.017
doi: 10.1016/j.seizure.2017.02.017
pubmed: 28284559
Holmes GL (2015) Cognitive impairment in epilepsy: the role of network abnormalities. Epileptic Disord 17:101–116. https://doi.org/10.1684/epd.2015.0739
doi: 10.1684/epd.2015.0739
pubmed: 25905906
pmcid: 5410366
Helmstaedter C, Aldenkamp AP, Baker GA et al (2014) Disentangling the relationship between epilepsy and its behavioral comorbidities — the need for prospective studies in new-onset epilepsies. Epilepsy Behav 31:43–47. https://doi.org/10.1016/j.yebeh.2013.11.010
doi: 10.1016/j.yebeh.2013.11.010
pubmed: 24333577
Novak A, Vizjak K, Rakusa M (2022) Cognitive impairment in people with epilepsy. J Clin Med 11:267. https://doi.org/10.3390/jcm11010267
doi: 10.3390/jcm11010267
pubmed: 35012007
pmcid: 8746065
Grzegorzewska AM, Wiglusz MS, Cubała WJ et al (2021) Dysphoria and irritability—diagnostic pitfalls in the assessment of interictal dysphoric disorder in epilepsy. J Clin Med 10:4624. https://doi.org/10.3390/jcm10194624
doi: 10.3390/jcm10194624
pubmed: 34640642
pmcid: 8509667
Grzegorzewska AM, Wiglusz MS, Landowski J et al (2021) Multiple comorbidity profile of psychiatric disorders in epilepsy. J Clin Med 10:4104. https://doi.org/10.3390/jcm10184104
doi: 10.3390/jcm10184104
pubmed: 34575214
pmcid: 8465099
Rakusa M, Jensterle J, Mlakar J (2018) Clock drawing test: a simple scoring system for the accurate screening of cognitive impairment in patients with mild cognitive impairment and dementia. Dement Geriatr Cogn Disord 45:326–334. https://doi.org/10.1159/000490381
doi: 10.1159/000490381
pubmed: 30036864
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6
doi: 10.1016/0022-3956(75)90026-6
pubmed: 1202204
Rakuša M, Granda G, Kogoj A et al (2006) Mini-mental state examination: standardisation and validation for the elderly Slovenian population. Eur J Neurol. https://doi.org/10.1111/j.1468-1331.2006.01185.x
doi: 10.1111/j.1468-1331.2006.01185.x
pubmed: 16490044
Kueper JK, Speechley M, Montero-Odasso M (2018) The Alzheimer’s disease assessment scale-cognitive subscale (ADAS-Cog): modifications and responsiveness in pre-dementia populations. A narrative review. J Alzheimer’s Dis 63:423–444. https://doi.org/10.3233/JAD-170991
doi: 10.3233/JAD-170991
Ulbl J, Rakusa M (2021) The standardisation of Slovenian version of Alzheimer’s disease assessment scale – cognitive subscale (ADAS-Cog). Česka a Slov Neurol a Neurochir 84/117:381–387. https://doi.org/10.48095/cccsnn2021381
doi: 10.48095/cccsnn2021381
Ulbl J, Rakusa M (2021) Validation of Slovenian version of ADAS-Cog for patients with mild cognitive impairment and Alzheimer’s disease. Acta Neurol Belg 122:695–702. https://doi.org/10.1007/s13760-021-01780-5
doi: 10.1007/s13760-021-01780-5
Nasreddine Z, Phillips N, Bédirian V et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
doi: 10.1111/j.1532-5415.2005.53221.x
pubmed: 15817019
Bartos A, Fayette D (2018) Validation of the Czech Montreal cognitive assessment for mild cognitive impairment due to Alzheimer disease and Czech norms in 1,552 elderly persons. Dement Geriatr Cogn Disord 46:335–345. https://doi.org/10.1159/000494489
doi: 10.1159/000494489
pubmed: 30513529
Biundo R, Weis L, Bostantjopoulou S (2016) MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. J neural Transm Vienna Austria 123:431–438. https://doi.org/10.1007/s00702-016-1517-6
doi: 10.1007/s00702-016-1517-6
Potocnik J, Ovcar Stante K, Rakusa M (2020) The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke. Acta Neurol Belg 120:681–685. https://doi.org/10.1007/s13760-020-01330-5
doi: 10.1007/s13760-020-01330-5
pubmed: 32193731
Wang L, Chen S, Liu C et al (2020) Factors for cognitive impairment in adult epileptic patients. Brain Behav. https://doi.org/10.1002/brb3.1475
doi: 10.1002/brb3.1475
pubmed: 33377600
pmcid: 7882180
Xu S, Xi J, Lin C et al (2018) Cognitive decline and white matter changes in mesial temporal lobe epilepsy. Medicine (Baltimore) 97:e11803. https://doi.org/10.1097/MD.0000000000011803
doi: 10.1097/MD.0000000000011803
pubmed: 30113469
Gavrilovic A, Toncev G, Boskovic Matic T et al (2019) Impact of epilepsy duration, seizure control and EEG abnormalities on cognitive impairment in drug-resistant epilepsy patients. Acta Neurol Belg 119:403–410. https://doi.org/10.1007/s13760-019-01090-x
doi: 10.1007/s13760-019-01090-x
pubmed: 30737651
Harby SA, Nassra RA, Mekky JF et al (2020) Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: a sensitive monitoring biomarker in patients with epilepsy. Seizure 78:71–77. https://doi.org/10.1016/j.seizure.2020.03.009
doi: 10.1016/j.seizure.2020.03.009
pubmed: 32213443
Li X-Y, Hu P, Li Q-Y et al (2019) Correlations between the level of antibody against peptide of glutamate receptor NR3B subunit in the CSF and cognitive comorbidities of patients with epilepsy. Eur Rev Med Pharmacol Sci 23:328–337. https://doi.org/10.26355/eurrev_201901_16780
doi: 10.26355/eurrev_201901_16780
pubmed: 30657574
Lin H, Leng X, Qin C et al (2020) Altered white matter structural network in frontal and temporal lobe epilepsy: a graph-theoretical study. Front Neurol 11:561. https://doi.org/10.3389/fneur.2020.00561
doi: 10.3389/fneur.2020.00561
pubmed: 32625164
pmcid: 7311567
Phabphal K, Kanjanasatien J (2011) Montreal cognitive assessment in cryptogenic epilepsy patients with normal mini-mental state examination scores. Epileptic Disord 13:375–381. https://doi.org/10.1684/epd.2011.0469
doi: 10.1684/epd.2011.0469
pubmed: 22258041
Zhang C, Yang H, Qin W et al (2017) Characteristics of resting-state functional connectivity in intractable unilateral temporal lobe epilepsy patients with impaired executive control function. Front Hum Neurosci 11:609. https://doi.org/10.3389/fnhum.2017.00609
doi: 10.3389/fnhum.2017.00609
pubmed: 29375338
pmcid: 5770650
Yang H, Zhang C, Liu C et al (2018) Brain network alteration in patients with temporal lobe epilepsy with cognitive impairment. Epilepsy Behav 81:41–48. https://doi.org/10.1016/j.yebeh.2018.01.024
doi: 10.1016/j.yebeh.2018.01.024
pubmed: 29475172
Karaaslan Ö, Hamamcı M (2020) Cognitive impairment profile differences in patients with psychogenic non-epileptic seizures and epilepsy patients with generalised seizures. Neurol Res 42:179–188. https://doi.org/10.1080/01616412.2020.1716468
doi: 10.1080/01616412.2020.1716468
pubmed: 31971099
Yao X, Yu Q, Yang E et al (2014) Executive dysfunction in patients with temporal lobe epilepsy and its correlation with P300. Zhonghua Yi Xue Za Zhi 94:521–524. https://doi.org/10.3760/cma.j.issn.0376-2491.2014.07.012
doi: 10.3760/cma.j.issn.0376-2491.2014.07.012
pubmed: 24767295
Rodrigues SG, Gouveia RG, Bentes C (2020) MoCA as a cognitive assessment tool for absence status epilepticus. Epileptic Disord 22:229–232. https://doi.org/10.1684/epd.2020.1149
doi: 10.1684/epd.2020.1149
pubmed: 32301729
Wong A, Law LSN, Liu W et al (2015) Montreal cognitive assessment: one cutoff never fits all. Stroke 46:3547–3550. https://doi.org/10.1161/STROKEAHA.115.011226
doi: 10.1161/STROKEAHA.115.011226
pubmed: 26470772
Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482. https://doi.org/10.1111/epi.12550
doi: 10.1111/epi.12550
pubmed: 24730690
Witt J-A, Elger CE, Helmstaedter C (2013) Impaired verbal fluency under topiramate - evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy. Eur J Neurol 20:130–137. https://doi.org/10.1111/j.1468-1331.2012.03814.x
doi: 10.1111/j.1468-1331.2012.03814.x
pubmed: 22827489
Park S-P, Hwang Y-H, Lee H-W et al (2008) Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients. Epilepsy Behav 12:102–108. https://doi.org/10.1016/j.yebeh.2007.08.002
doi: 10.1016/j.yebeh.2007.08.002
pubmed: 17945539
Montaño-Lozada JM, López N, Espejo-Zapata LM et al (2021) Cognitive changes in patients with epilepsy identified through the MoCA test during neurology outpatient consultation. Epilepsy Behav 122:108158. https://doi.org/10.1016/j.yebeh.2021.108158
doi: 10.1016/j.yebeh.2021.108158
pubmed: 34182417
Zacharia TT, Eslinger PJ (2019) Functional MRI activation patterns of cerebellum in patients with epilepsy and brain tumors. Clin Anat 32:1053–1060. https://doi.org/10.1002/ca.23439
doi: 10.1002/ca.23439
pubmed: 31376291
Nakhutina L, Kunnakkat SD, Coleman M et al (2017) Effects of adjunctive lacosamide on mood and quality of life in patients with epilepsy. Epilepsy Behav 73:90–94. https://doi.org/10.1016/j.yebeh.2017.05.001
doi: 10.1016/j.yebeh.2017.05.001
pubmed: 28623755
Miller LA, Galioto R, Tremont G et al (2016) Cognitive impairment in older adults with epilepsy: characterisation and risk factor analysis. Epilepsy Behav 56:113–117. https://doi.org/10.1016/j.yebeh.2016.01.011
doi: 10.1016/j.yebeh.2016.01.011
pubmed: 26859320
Piazzini A, Canevini MP, Turner K et al (2006) Elderly people and epilepsy: cognitive function. Epilepsia 47:82–84. https://doi.org/10.1111/j.1528-1167.2006.00884.x
doi: 10.1111/j.1528-1167.2006.00884.x
pubmed: 17239113
Martin RC, Griffith HR, Faught E et al (2005) Cognitive functioning in community dwelling older adults with chronic partial epilepsy. Epilepsia 46:298–303. https://doi.org/10.1111/j.0013-9580.2005.02104.x
doi: 10.1111/j.0013-9580.2005.02104.x
pubmed: 15679511
Griffith HR, Martin RC, Bambara JK et al (2006) Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment. Epilepsy Behav 8:161–168. https://doi.org/10.1016/j.yebeh.2005.09.004
doi: 10.1016/j.yebeh.2005.09.004
pubmed: 16266829
Gul A, Ahmad H (2015) Thought suppression predicts task switching deficits in patients with frontal lobe epilepsy. Neurosciences 20:153–158. https://doi.org/10.17712/nsj.2015.2.20140652
doi: 10.17712/nsj.2015.2.20140652
pubmed: 25864068
pmcid: 4727630
Witt J-A, Helmstaedter C (2015) Cognition in the early stages of adult epilepsy. Seizure 26:65–68. https://doi.org/10.1016/j.seizure.2015.01.018
doi: 10.1016/j.seizure.2015.01.018
pubmed: 25799904